Evidence map›Paper›PMID 40893393›Full record

ArticleClinical case reports2025

Navigating Rare Presentations: Recurrent Burkitt Lymphoma Presenting as a Jejunal Mass.

Tejas Nikumbh, Archit Garg, Himani Mongia, Tushar Abhinav, Nivesh Yadav, Udit Asija, Jialing Huang, Danial Nadeem, Kishore Kumar, Amit Sohagia

Abstract read
In one paragraph

Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tejas NikumbhThe Wright Center for Graduate Medical Education Scranton Pennsylvania United States.ORCID https://orcid.org/0000-0002-0167-6761
Archit GargSt Peter's University Hospital New Brunswick New Jersey United States.
Himani MongiaThe Wright Center for Graduate Medical Education Scranton Pennsylvania United States.
Tushar AbhinavThe Wright Center for Graduate Medical Education Scranton Pennsylvania United States.
Nivesh YadavThe Wright Center for Graduate Medical Education Scranton Pennsylvania United States.
Udit AsijaThe Wright Center for Graduate Medical Education Scranton Pennsylvania United States.
Jialing HuangGeisinger Community Medical Center Scranton Pennsylvania United States.
Danial NadeemGeisinger Community Medical Center Scranton Pennsylvania United States.
Kishore KumarGeisinger Community Medical Center Scranton Pennsylvania United States.
Amit SohagiaGeisinger Community Medical Center Scranton Pennsylvania United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Burkitt lymphoma (BL) is an aggressive B-cell malignancy characterized by rapid progression and MYC gene translocations. Jejunal involvement in BL is rare compared to more common sites like the lymph nodes and central nervous system. Diagnosing BL in the jejunum is particularly challenging as it can mimic other gastrointestinal conditions, necessitating a high index of suspicion and histopathological confirmation. We present the case of a 37-year-old male with a history of stage III non-seminomatous testicular carcinoma, BL, deep venous thrombosis, pulmonary embolism, and hypogammaglobulinemia, who presented with abdominal pain and nausea. Imaging revealed peritoneal carcinomatosis and a left hemiabdomen mass concerning malignancy. Given his medical history of previously diagnosed BL in the gastrohepatic ligament lymph node and imaging findings, BL relapse was suspected. Push enteroscopy with biopsy confirmed the recurrence of BL in the jejunum, with positive markers for CD45, CD20, BCL6, and c-Myc. Despite aggressive supportive care, the patient succumbed to his disease. This case highlights the importance of early recognition of BL, particularly in rare extra-nodal sites like the jejunum. Further research is needed to improve early detection and treatment outcomes for patients with relapsed or refractory BL.

Indexed as

burkitt lymphomajejunal involvementlymphoma recurrencerelapsetumor lysis syndrome

Identifiers

PMID40893393
PMCPMC12394064

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.